AntimetabolitesAntimetabolites, AntineoplasticSurgical SpongesThioguanine6-MercaptopurineVidarabine Phosphate6-AminonicotinamideTetrahydrouridineFluorouracilTrabeculectomyPantothenic AcidAntineoplastic AgentsNorleucineMethotrexateDeoxycytidineMitomycinCytarabineFloxuridinePhosphonoacetic AcidNeoplasmsThymidylate SynthaseAzathioprineLeukemia L1210GuanineStreptomycesTumor Cells, CulturedDrug SynergismApoptosisCell SurvivalCell DivisionCell Line, TumorDrug Screening Assays, AntitumorAntineoplastic Combined Chemotherapy ProtocolsCell LineAntineoplastic Agents, PhytogenicXenograft Model Antitumor AssaysDrug Resistance, NeoplasmInhibitory Concentration 50Cell ProliferationDoxorubicinMice, NudeAntibiotics, AntineoplasticPlant ExtractsDrug Delivery SystemsMolecular StructureDrug CarriersCisplatinDrug DesignDose-Response Relationship, DrugProdrugsCell CycleCamptothecinEllipticinesAnticarcinogenic AgentsPaclitaxelEtoposideEnzyme InhibitorsPhytotherapyBreast NeoplasmsHT29 CellsGene Expression Regulation, NeoplasticColonic NeoplasmsDrug Resistance, MultipleNanomedicineDrug Evaluation, PreclinicalP-GlycoproteinHCT116 CellsNanoparticlesSignal TransductionStructure-Activity RelationshipTopoisomerase I InhibitorsMolecular Targeted TherapyMCF-7 CellsTopoisomerase InhibitorsCaspasesNeoplasm TransplantationTubulin ModulatorsLung NeoplasmsCaspase 3DNA DamageCell Cycle CheckpointsDNA Topoisomerases, Type IIClinical Trials, Phase I as TopicNeoplasms, ExperimentalTriterpenesCell DeathXanthonesProto-Oncogene Proteins c-bcl-2Tumor Suppressor Protein p53CurcuminBlotting, WesternPlatinumTumor BurdenHistone Deacetylase InhibitorsCoordination ComplexesIntercalating AgentsDrug DiscoveryMice, Inbred BALB CDaunorubicinAngiogenesis Inhibitors